Scilla, K. A., Bentzen, S. M., Lam, V. K., Mohindra, P., Nichols, E. M., Vyfhuis, M. A., . . . Feliciano, J. L. (2017). Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy. Oncologist.
Chicago ZitierstilScilla, Katherine A., et al. "Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients With Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated With Combined Modality Therapy." Oncologist 2017.
MLA ZitierstilScilla, Katherine A., et al. "Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients With Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated With Combined Modality Therapy." Oncologist 2017.